'Not much' continues to be the assessment of what's going on QTRH. The stock is down 19% this year. The balance sheet has weakened this year, with net debt about $10M more than at 2023 year end. Cash flow has been weak, and the company has missed estimates in eight straight quarters. Another loss is expected this year, with a smaller loss (1c) expected in 2025. There has been a bit of insider buying this year. It has formed a technical advisory committee to consider its technology roadmap going forward. It remains very hard to endorse the stock.
5i Research Answer: